Cargando…

Presumed population immunity to SARS-CoV-2 in South Korea, April 2022

OBJECTIVES: We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as of April 2022 using the national registry. METHODS: We used the national coronavirus disease 2019 (COVID-19) infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Eun Jung, Choe, Young June, Choe, Seung Ah, Kim, Yoo-Yeon, Kim, Ryu Kyung, Kim, Jia, Lim, Do Sang, Lee, Ju Hee, Yi, Seonju, Lee, Sangwon, Park, Young-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Disease Control and Prevention Agency 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633270/
https://www.ncbi.nlm.nih.gov/pubmed/36328242
http://dx.doi.org/10.24171/j.phrp.2022.0209
_version_ 1784824226954346496
author Jang, Eun Jung
Choe, Young June
Choe, Seung Ah
Kim, Yoo-Yeon
Kim, Ryu Kyung
Kim, Jia
Lim, Do Sang
Lee, Ju Hee
Yi, Seonju
Lee, Sangwon
Park, Young-Joon
author_facet Jang, Eun Jung
Choe, Young June
Choe, Seung Ah
Kim, Yoo-Yeon
Kim, Ryu Kyung
Kim, Jia
Lim, Do Sang
Lee, Ju Hee
Yi, Seonju
Lee, Sangwon
Park, Young-Joon
author_sort Jang, Eun Jung
collection PubMed
description OBJECTIVES: We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as of April 2022 using the national registry. METHODS: We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity. RESULTS: Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80% to 85%; however, nearly half of the children were presumed to have no immunity. CONCLUSION: We report a gap in population immunity, with lower presumed protection in children than in adults. The approach presented in this work can provide valuable informed tools to assist vaccine policy-making at a national level.
format Online
Article
Text
id pubmed-9633270
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korea Disease Control and Prevention Agency
record_format MEDLINE/PubMed
spelling pubmed-96332702022-11-16 Presumed population immunity to SARS-CoV-2 in South Korea, April 2022 Jang, Eun Jung Choe, Young June Choe, Seung Ah Kim, Yoo-Yeon Kim, Ryu Kyung Kim, Jia Lim, Do Sang Lee, Ju Hee Yi, Seonju Lee, Sangwon Park, Young-Joon Osong Public Health Res Perspect Brief Report OBJECTIVES: We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as of April 2022 using the national registry. METHODS: We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity. RESULTS: Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80% to 85%; however, nearly half of the children were presumed to have no immunity. CONCLUSION: We report a gap in population immunity, with lower presumed protection in children than in adults. The approach presented in this work can provide valuable informed tools to assist vaccine policy-making at a national level. Korea Disease Control and Prevention Agency 2022-10 2022-10-14 /pmc/articles/PMC9633270/ /pubmed/36328242 http://dx.doi.org/10.24171/j.phrp.2022.0209 Text en © 2022 Korea Disease Control and Prevention Agency. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Brief Report
Jang, Eun Jung
Choe, Young June
Choe, Seung Ah
Kim, Yoo-Yeon
Kim, Ryu Kyung
Kim, Jia
Lim, Do Sang
Lee, Ju Hee
Yi, Seonju
Lee, Sangwon
Park, Young-Joon
Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
title Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
title_full Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
title_fullStr Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
title_full_unstemmed Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
title_short Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
title_sort presumed population immunity to sars-cov-2 in south korea, april 2022
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633270/
https://www.ncbi.nlm.nih.gov/pubmed/36328242
http://dx.doi.org/10.24171/j.phrp.2022.0209
work_keys_str_mv AT jangeunjung presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT choeyoungjune presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT choeseungah presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT kimyooyeon presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT kimryukyung presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT kimjia presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT limdosang presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT leejuhee presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT yiseonju presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT leesangwon presumedpopulationimmunitytosarscov2insouthkoreaapril2022
AT parkyoungjoon presumedpopulationimmunitytosarscov2insouthkoreaapril2022